PERIOD ENDING | 29-May-09 | 27-Feb-09 | 28-Nov-08 | 29-Aug-08 | Total Revenue | 704,673 | 786,390 | 915,301 | 887,257 | Cost of Revenue | 72,008 | 77,353 | 86,438 | 110,851 | | Gross Profit | 632,665 | 709,037 | 828,863 | 776,406 | | | Operating Expenses | | Research Development | 138,470 | 149,917 | 153,148 | 170,124 | | Selling General and Administrative | 314,027 | 323,542 | 356,070 | 368,595 | | Non Recurring | 3,531 | 12,270 | 29,428 | 1,194 | | Others | 15,284 | 15,392 | 17,024 | 17,024 | | | | Total Operating Expenses | 471,312 | 501,121 | 555,670 | 556,937 | | | Operating Income or Loss | 161,353 | 207,916 | 273,193 | 219,469 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,997 | (3,962) | 5,143 | 11,435 | | Earnings Before Interest And Taxes | 164,350 | 203,954 | 278,336 | 230,904 | | Interest Expense | 620 | 792 | 1,992 | 2,390 | | Income Before Tax | 163,730 | 203,162 | 276,344 | 228,514 | | Income Tax Expense | 37,659 | 46,727 | 30,427 | 36,906 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 126,071 | 156,435 | 245,917 | 191,608 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | Net Income | 126,071 | 156,435 | 245,917 | 191,608 | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | Net Income Applicable To Common Shares | $126,071 | $156,435 | $245,917 | $191,608 |
|